Oyster Point Medical LLC
PrivateLast Round
M&A
Jan 3, 2023
Est. Valuation
$415M
Total Funding Raised
$235.8M
Company Overview
Oyster Point Medical LLC is a medical device company that provides contract manufacturing and prototyping services for advanced interventional technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oyster Point Medical LLC Comparables
Compare Oyster Point Medical LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harrow, Inc. | 82% | |
| Bausch + Lomb Corporation | 78% | |
| Novaliq | 77% |
Oyster Point Medical LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jan 3, 2023 | ||||
| Follow-on Offering | May 19, 2020 | ||||
| IPO | Oct 30, 2019 | ||||
| Series B | Feb 26, 2019 | ||||
| Series A | Nov 7, 2017 |
Oyster Point Medical LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Series B, Series A |
| J.P. Morgan Securities (Asia Pacific) Limited | IPO |
| Vida Ventures | Series B |
| Invus Opportunities | Series B |
| Flying L Partners | Series B |
| Versant Ventures | Series B, Series A |
| Falcon Vision | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 3, 2023
$415M round led by Viatris Inc.
- Oct 30, 2019
$92M IPO round led by J.P. Morgan Securities and Piper Sandler.
Oyster Point Medical LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access